Baird Steps Back as ACN Trades Through Its Own Price Target

Baird downgraded Accenture to Neutral this morning, even as it lifted its price target to $252. The stock closed Tuesday at $239, already 12% higher on the week, and has now run past several analyst targets that were set just weeks ago.

The Analyst Picture

The downgrade is a valuation call, not a fundamental one. Baird's David Koning raised his target by $7 but pulled the rating, a combination that says the stock caught up with the thesis faster than expected.

The broader analyst community is still catching up. TD Cowen sits at $201. Susquehanna is at $230. Wells Fargo has $210. All three raised targets within the past week, yet the stock has already blown past every one of them. The consensus stands at Hold, with a mean target of $227, roughly $12 below where the stock is trading now.

Goldman Sachs, at $260, and Evercore ISI, at $250, remain the outliers with room for the stock to run. Goldman maintains Buy. For everyone else, the 32% one-month rally has closed the gap.

Shorts Re-enter, Borrow Stays Cheap

Short interest has risen 10% this week to 3.7% of the free float, reversing a steady decline that followed October's earnings print. That print, an 8.5% single-day gain on October 1, forced heavy covering. SI had dropped to a low of around 20.9 million shares by October 9. It has since climbed back to 22.9 million.

The borrow market tells a different story from six days ago. The prior convergence report on this stock covered a 755% spike in cost to borrow on October 13 to 6.78%, which briefly made the lending picture look complicated. That has fully reversed. Cost to borrow is now 0.57%, down 92% on the week, the lowest since early October. Availability remains deep at 1,014%, more than ten shares available for every one currently lent out. The short rebuild is being done cheaply and easily.

Options Hedging at a 52-Week High

The options put/call ratio reached 1.13 on October 16, the highest level since late August, and the 52-week high for the series. It has since eased to 0.98. The move happened as the stock was rallying hard. Buyers of downside protection were paying up precisely when the stock felt most expensive relative to where analysts had it priced.

The PCR has now pulled back to near its 20-day mean of 1.0. The hedging spike, at least by this measure, looks like a reaction to the pace of the rally rather than a structural shift in positioning.

Retail Attention Running Hot

Wikipedia pageviews for Accenture hit a z-score of 2.17 against the company's own 90-day history as of October 2, per Wikimedia Foundation data tracked by ORTEX. That level of retail attention is high relative to the stock's own baseline, consistent with a name drawing renewed interest after a prolonged drawdown. Accenture had fallen nearly a fifth in value earlier this year before this recovery began.

BlackRock added 5 million shares in the quarter to September 30, the largest disclosed institutional move among top holders. State Street added 2 million. Those flows predate the recent rally but confirm index and active managers were rebuilding positions at lower prices.

What to watch: The next earnings date is December 17. The stock now trades above the mean analyst target. Any analyst who raised to $230 or below in the past two weeks is already offside. Watch whether further upgrades or target hikes materialise, or whether the stock drifts back toward the $227 consensus in the weeks ahead.